Drug Shortage Report for SANDOZ DEFERASIROX (TYPE J)

Last updated on 2025-04-22 History
Report ID 247593
Drug Identification Number 02489902
Brand name SANDOZ DEFERASIROX (TYPE J)
Common or Proper name DEFERASIROX (TYPE J)
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) DEFERASIROX
Strength(s) 180MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 30FCT
ATC code V03AC
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2025-01-13
Estimated end date 2025-04-18
Actual end date 2025-04-21
Shortage status Resolved
Updated date 2025-04-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2025-04-22 French Compare
v10 2025-04-22 English Compare
v9 2025-04-07 French Compare
v8 2025-04-07 English Compare
v7 2025-03-24 French Compare
v6 2025-03-24 English Compare
v5 2025-02-03 French Compare
v4 2025-02-03 English Compare
v3 2025-01-13 French Compare
v2 2025-01-13 English Compare
v1 2025-01-13 English Compare

Showing 1 to 11 of 11